Deferred Tax Assets, Net of Valuation Allowance of Fulgent Genetics, Inc. from 30 Sep 2016 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Fulgent Genetics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Sep 2016 to 31 Dec 2025.
Fulgent Genetics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $32,767,000, a 6.6% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Fulgent Genetics, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$32,767,000	+$2,023,000	+6.6%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q4 2024	$30,744,000	+$925,000	+3.1%	31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q4 2023	$29,819,000	-$23,936,000	-45%	31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q4 2022	$53,755,000	+$34,444,000	+178%	31 Dec 2022	10-K	28 Feb 2024	2023	FY
Q4 2021	$19,311,000	+$12,482,000	+183%	31 Dec 2021	10-K	28 Feb 2023	2022	FY
Q4 2020	$6,829,000	+$5,747,000	+531%	31 Dec 2020	10-K	28 Feb 2022	2021	FY
Q4 2019	$1,082,000	+$364,000	+51%	31 Dec 2019	10-K	28 Feb 2022	2021	FY
Q4 2018	$718,000	-$228,000	-24%	31 Dec 2018	10-K	13 Mar 2020	2019	FY
Q4 2017	$946,000	+$142,000	+18%	31 Dec 2017	10-K	22 Mar 2019	2018	FY
Q3 2017	$27,000	-$59,000	-69%	30 Sep 2017	10-Q	13 Nov 2017	2017	Q3
Q2 2017	$37,000			30 Jun 2017	10-Q	14 Aug 2017	2017	Q2
Q1 2017	$44,000			31 Mar 2017	10-Q	09 May 2017	2017	Q1
Q4 2016	$804,000			31 Dec 2016	10-K	20 Mar 2018	2017	FY
Q3 2016	$86,000			30 Sep 2016	10-Q	14 Nov 2016	2016	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.